Hypoxia-preconditioned mesenchymal stromal cells improve cardiac function in a swine model of chronic myocardial ischaemia.
about
Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapyHypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro.Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosisPreconditioning of bone marrow mesenchymal stem cells by prolyl hydroxylase inhibition enhances cell survival and angiogenesis in vitro and after transplantation into the ischemic heart of ratsManganese-Enhanced Magnetic Resonance Imaging Enables In Vivo Confirmation of Peri-Infarct Restoration Following Stem Cell Therapy in a Porcine Ischemia-Reperfusion Model.Short-term memory of danger signals or environmental stimuli in mesenchymal stem cells: implications for therapeutic potential.A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization.Hypoxia-preconditioned allogeneic mesenchymal stem cells can be used for myocardial repair in non-human primates.Priming adult stem cells by hypoxic pretreatments for applications in regenerative medicine.Hypoxia enhances protective effect of placental-derived mesenchymal stem cells on damaged intestinal epithelial cells by promoting secretion of insulin-like growth factor-1.Fortune Favors the Prepared: Safety and Efficacy of Allogeneic Hypoxia Preconditioned Mesenchymal Stromal Cells in Primates.Evaluation of Left Ventricular Regional Systolic Function Using Tissue Doppler Echocardiography After Mesenchymal Stem Cell Transplantation in Rabbits With Myocardial Infarction.Recent Progress in Stem Cell Modification for Cardiac Regeneration.Improvement of Cell Cycle Lifespan and Genetic Damage Susceptibility of Human Mesenchymal Stem Cells by Hypoxic Priming.
P2860
Q29994669-31DE94F1-18ED-45CC-A6A7-004C9B65D405Q35779127-EE74C6E6-4318-4022-86B4-E81E3CE28249Q35805322-4EA88FA5-B55A-468A-99C6-8C7EE8EE2C57Q35949645-D572F7D5-C3EC-43FA-B0FE-B399BAE104AFQ36168811-F52CF3CA-2B57-4342-926D-3F7EEDF138AAQ36870042-5EFCB77F-8B1B-40F7-AF1E-B0005733F00DQ36973427-4ACB5443-0B80-4180-B019-5F9C6793FF9AQ37121472-3824048E-B721-45CC-9A16-A2AB4FD3770EQ37153287-15AAF73C-05E1-4A96-80B5-780C557957A7Q37645132-CCDA8C0B-0978-46C1-89B3-5B77794F60FCQ42337705-2F8C6082-CE70-4211-BEAB-8FC26E34ECFBQ42478906-9B593F01-1F1E-4F3B-9AA8-5D62C7442818Q52657125-AFE31968-B43A-449B-B080-1BD1B85C58AFQ52716442-F9D1D908-1518-4CC9-806F-6923656D3F60
P2860
Hypoxia-preconditioned mesenchymal stromal cells improve cardiac function in a swine model of chronic myocardial ischaemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Hypoxia-preconditioned mesench ...... chronic myocardial ischaemia.
@en
Hypoxia-preconditioned mesench ...... chronic myocardial ischaemia.
@nl
type
label
Hypoxia-preconditioned mesench ...... chronic myocardial ischaemia.
@en
Hypoxia-preconditioned mesench ...... chronic myocardial ischaemia.
@nl
prefLabel
Hypoxia-preconditioned mesench ...... chronic myocardial ischaemia.
@en
Hypoxia-preconditioned mesench ...... chronic myocardial ischaemia.
@nl
P2093
P2860
P356
P1476
Hypoxia-preconditioned mesench ...... chronic myocardial ischaemia.
@en
P2093
Jean Chevaleyre
Jeremie Jaussaud
Joachim Calderon
Laurent Barandon
Matthieu Biais
Pascale Duchez
Thierry Couffinhal
P2860
P304
P356
10.1093/EJCTS/EZS549
P577
2012-10-25T00:00:00Z